TCG Crossover is a science-driven investment firm dedicated to advancing disruptive medicines.
AUM: $5.1B · Form ADV, 29 May 2026
Cariad ChesterManaging Partner · Present
Charles SawyersScience Partner · Present
Charles ZukerScience Partner · Present
Chen YuManaging Partner · Present
Dandan DongManaging Partner · Present
Giuliano MarosticaManaging Partner · Present
Helen HobbsScience Partner · Present
Huda Y. ZoghbiScience Partner · Present
Richard SchellerScience Partner · Present
Robert TjianScience Partner · Present
Roger PerlmutterScience Partner · Present
Vishva M. DixitScience Partner · Present